RUBICON BIOTECHNOLOGY - About the company
RUBICON BIOTECHNOLOGY is a funded company based in Orange (United States). It operates as a Developer of fusion protein therapies for treating cellular stress injuries. RUBICON BIOTECHNOLOGY has raised an undisclosed amount in funding. The company has 1880 active competitors, including 96 funded and 203 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Company Details
Developer of fusion protein therapies for treating cellular stress injuries. This entity focuses on creating biologics designed to protect cells from hypoxic and oxidative damage. Research efforts target medical conditions related to cardiology, neurology, ophthalmology, and oncology. The business model involves advancing clinical studies through collaboration with research and manufacturing organizations to facilitate the licensing of proprietary technology to pharmaceutical entities.
Key Metrics
Location
Orange, United States
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
966th among 1880 active competitors
Sign up to download RUBICON BIOTECHNOLOGY's company profile
RUBICON BIOTECHNOLOGY's funding and investors
RUBICON BIOTECHNOLOGY has raised funding over 2 rounds. Its first funding round was on Sep 25, 2013. Its latest funding round was a Grant (prize money) round on Feb 08, 2017 for $*****. 1 investor participated in its latest round. RUBICON BIOTECHNOLOGY has 1 institutional investor.
Here is the list of recent funding rounds of RUBICON BIOTECHNOLOGY:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 08, 2017 | 3349226 | Grant (prize money) | 2574555 | 4016872 | 4552916 | 4275514 |
Sep 25, 2013 | 4278414 | Grant (prize money) | 1507944 | 6472811 | 5251180 |
Access funding benchmarks and valuations. Sign up today!View details of RUBICON BIOTECHNOLOGY's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
RUBICON BIOTECHNOLOGY's Competitors and alternates
Top competitors of RUBICON BIOTECHNOLOGY include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of RUBICON BIOTECHNOLOGY, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
3rd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
4th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
7th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 72/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 | |
966th |  RUBICON BIOTECHNOLOGY Orange (United States), Funding Raised | Developer of fusion protein therapies for treating cellular stress injuries | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on RUBICON BIOTECHNOLOGY's competitors? Click here to see the top ones
RUBICON BIOTECHNOLOGY's Investments and acquisitions
RUBICON BIOTECHNOLOGY has made no investments or acquisitions yet.
Reports related to RUBICON BIOTECHNOLOGY
Here is the latest report on RUBICON BIOTECHNOLOGY's sector:
Are you a Founder ?
FAQs about RUBICON BIOTECHNOLOGY
Explore our recently published companies
- Katoora - United Arab Emirates based, Unfunded company
- RD Marketing - Vancouver based, Unfunded company
- Akwaaba Feeds - Accra based, 2017 founded, Seed company
- HousApp - United Kingdom based, 2024 founded, Seed company
- Scinvivo - Amsterdam based, 2016 founded, Series A company
- Bullet For My Valentine - Bridgend based, 2003 founded, Unfunded company
